CRANBURY, N.J.--(BUSINESS WIRE)--March 7, 2006--Valera Pharmaceuticals (NASDAQ:VLRX), a specialty pharmaceutical company focused on the development, acquisition and commercialization of products for the urology and endocrinology markets, today announced financial results for the year and fourth quarter ended December 31, 2005 and recapped certain milestone achievements.
